Innovative Technologies Impacted by COVID-19 Act
This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
To amend title XVIII of the Social Security Act to extend the pass-
                  through period for certain devices.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Innovative Technologies Impacted by 
COVID-19 Act''.

SEC. 2. EXTENDING PASS-THROUGH STATUS UNDER THE MEDICARE PROGRAM FOR 
              CERTAIN DEVICES.

    Section 1833(t)(6) of the Social Security Act (42 U.S.C. 
1395l(t)(6)) is amended by adding at the end the following new 
subparagraph:
                    ``(K) Pass-through extension for certain devices.--
                In the case of a device with respect to which the pass-
                through status under this paragraph would, but for 
                application of this subparagraph, end on December 31, 
                2022, such pass-through status shall be extended for 
                the 1-year period beginning on January 1, 2023.''.
                                 <all>
Innovative Technologies Impacted by COVID–19 Act
To amend title XVIII of the Social Security Act to extend the pass-through period for certain devices.
Innovative Technologies Impacted by COVID–19 Act
Rep. Schneider, Bradley Scott